[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Achives
 
Powered by Google
 

Public Hearing on Direct-to-Consumer Promotion of Medical Products
November 1 and 2, 2005
Presentations

Panel 1

  • Brief Summary Research: Improving Patient Comprehension [PPT] Sharon D. Allison-Ottey, COSHAR Inc.
  • Comprehension of Benefits vs. Risks: Fair balance in DTC? [PDF] Ruth Day, Duke University
  • Re-evaluating risk messages in TV drug commercials [PPT], Lewis Glinert, Ph.D., Dartmouth College
    The Effect of Direct to Consumer Television Advertising on the Timing of Treatment [PPT], Andrew N. Kleit, The Pennsylvania State University,

Panel 2

  • Advancing Public Health Through Effective Consumer Health Communication [PPT], Pat Kelly, Pfizer
  • Celebrities in Advertising: What Are They Likely or Not Likely To Do? [PDF], Abhilasha (Abby) Mehta, Ph.D., Gallup & Robinson, Inc.
  • Direct-to-Consumer Advertising of COX-2 Inhibitors: Effect on Appropriateness of Treatment [PPT], Michele Spence, Kaiser Permanente
  • Recent Sufferers: Exploring Patient Behavior From Discovery to Diagnosis [PPT], Christine Winnicki

Panel 3

  • Public Hearing on Direct-to-Consumer Promotion of Medical Products [PPT], James Gardner, One to One Interactive
  • Public Hearing on Direct-to-Consumer Promotion of Medical Products [PPT], Gail H. Javitt, JD, MPH, Johns Hopkins University
  • Consumer Directed Promotion of Regulated Medical Products [PPT], Bill Person, 50PlusWebHealth
  • FDA Public Hearing on Consumer-Directed Promotion of Regulated Medical Products AdvaMed Presentation [PPT], Marlene K. Tandy, M.D., J.D.,  Johnson & Johnson

Panel 4

  • Direct-to-Consumer Promotion of Regulated Medical Products [PPT], Gary C. Stein, Ph.D., American Society of Health-System Pharmacists
  • Direct-to-Consumer Promotion of Medical Products [PPT], Diana Zuckerman, Ph.D., National Research Center for Women & Families

Panel 5

  • Statement before the Food and Drug Administration Public Hearing on Direct-to-Consumer Advertising [PPT], Judith A. Cahill, Academy of Managed Care Pharmacy
  • Direct-to-consumer advertising of prescription medicines in the United States and New Zealand: An analysis of regulatory approaches and consumer responses [PPT], John E. Calfee, American Enterprise Institute
  • Food and Drug Administration Hearings on Direct to Consumer Advertising [PPT], James H. Davidson, Davidson & Company

Panel 6

  • DTCA: The Need for Greater Regulation and Enforcement [PPT], Alex Sugarman-Brozan, Prescription Access Litigation
  • DTC Advertising Hearing [PPT], Kim Witczak
  • FDA Public Hearing on Direct-to-Consumer Promotion of Medical Products [PPT], Meg Columbia-Walsh, Managing Director, Faith Popcorn’s BrainReserve
  • Gary Ruskin Testimony, Executive Directory, Commercial Alert [PDF]

Panel 7

  • FDA Public Hearing on Direct-to-Consumer Promotion of Medical Products [PPT], Meg Columbia-Walsh, Managing Director, Faith Popcorn’s BrainReserve

PDF requires the free Adobe Acrobat Reader

Back to Top     DTC Meeting Info

Date created: November 9, 2005, updated February 9, 2006
horizonal rule

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research